Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SynergEyes, a manufacturer of new Dk hybrid contact lens, has closed $13.3 million in series C financing to fund the development and clinical trials for next-generation hybrid contact lens products and to expand sales and marketing efforts globally.
Subscribe to our email newsletter
De Novo Ventures of Palo Alto, California, led this round as well as SynergEyes’s series B round. Bio-Star Private Equity Fund joined series A and B investors: Alloy Ventures, Delphi Ventures, InnoCal Venture Capital and Windward Ventures as a new investor.
The new SynergEyes investor, Bio-Star Private Equity Fund, believes the company has the potential to deliver a truly transformational vision correction product.
Jim Ham, CEO for SynergEyes, said: “SynergEyes hybrid contact lenses represent a significant advancement in the contact lens industry and give eye care professionals a one-of-a-kind tool to satisfy one of the largest growing patient categories in the world.”